Literature DB >> 5569980

Effect of age and sex on human drug metabolism.

K O'Malley, J Crooks, E Duke, I H Stevenson.   

Abstract

The capacity of inpatients in a geriatric hospital to metabolize drugs was measured. The mean plasma half-life values with antipyrine and with phenylbutazone were found to be 45% and 29% greater respectively in patients than in young controls. When women alone were considered the half-life of antipyrine was 78% longer in the elderly group. In a number of elderly individuals the rate of metabolism of these two drugs was found to be extremely slow. This decreased ability to metabolize drugs may contribute to the known high incidence of adverse drug reactions in the elderly.Within the control group a significant sex difference in the rate of antipyrine metabolism was found, the mean half-life being 30% longer in the males. It is clear from these results that the age and sex of subjects must be taken into account in studies of human drug metabolism.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5569980      PMCID: PMC1798743          DOI: 10.1136/bmj.3.5775.607

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  8 in total

1.  VARIATION IN THE ACTIVITY OF LIVER MICROSOMAL DRUG-METABOLIZING ENZYMES IN RATS IN RELATION TO THE AGE.

Authors:  R KATO; P VASSANELLI; G FRONTINO; E CHIESARA
Journal:  Biochem Pharmacol       Date:  1964-07       Impact factor: 5.858

2.  Pharmacological implications of microsomal enzyme induction.

Authors:  A H Conney
Journal:  Pharmacol Rev       Date:  1967-09       Impact factor: 25.468

3.  Genetic control of drug levels in man: antipyrine.

Authors:  E S Vesell; J G Page
Journal:  Science       Date:  1968-07-05       Impact factor: 47.728

4.  Increased antipyrine half-life in women taking oral contraceptives.

Authors:  K O'Malley; I H Stevenson; W Alexander
Journal:  Scott Med J       Date:  1970-12       Impact factor: 0.729

5.  The stimulation and inhibition of hepatic microsomal drug-metabolizing enzymes with special reference to effects of environmental contaminants.

Authors:  J R Fouts
Journal:  Toxicol Appl Pharmacol       Date:  1970-11       Impact factor: 4.219

6.  The physiological disposition of phenylbutazone (butazolidin) in man and a method for its estimation in biological material.

Authors:  J J BURNS; R K ROSE; T CHENKIN; A GOLDMAN; A SCHULERT; B B BRODIE
Journal:  J Pharmacol Exp Ther       Date:  1953-11       Impact factor: 4.030

7.  Genetic control of drug levels in man: phenylbutazone.

Authors:  E S Vesell; J G Page
Journal:  Science       Date:  1968-03-29       Impact factor: 47.728

8.  Predisposing factors in adverse reactions to drugs.

Authors:  N Hurwitz
Journal:  Br Med J       Date:  1969-03-01
  8 in total
  117 in total

1.  Pharmacokinetics in the aged: a review.

Authors:  E J Triggs; R L Nation
Journal:  J Pharmacokinet Biopharm       Date:  1975-12

2.  Clinical application of antipyrine half life in saliva in a patient with osteomalacia.

Authors:  H S Fraser; D Thompson; C Khan
Journal:  Br Med J       Date:  1976-06-19

3.  The effect of cirrhosis on the disposition and elimination of clindamycin.

Authors:  G R Avant; S Schenker; R H Alford
Journal:  Am J Dig Dis       Date:  1975-03

Review 4.  Beta-adrenergic blockers in systemic hypertension: pharmacokinetic considerations related to the current guidelines.

Authors:  William H Frishman; Mamata Alwarshetty
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 5.  Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications.

Authors:  A A Mangoni; S H D Jackson
Journal:  Br J Clin Pharmacol       Date:  2004-01       Impact factor: 4.335

6.  The "top 50": a perspective on the BMJ drawn from the Science Citation Index.

Authors:  B Dixon
Journal:  BMJ       Date:  1990-10-03

Review 7.  Hepatic drug metabolism and aging.

Authors:  C Durnas; C M Loi; B J Cusack
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

8.  Influence of age, sex, pregnancy and protein-calorie malnutrition on the pharmacokinetics of salicylate in rats.

Authors:  D R Varma; T L Yue
Journal:  Br J Pharmacol       Date:  1984-05       Impact factor: 8.739

9.  Age related differences in the disposition of acetanilide.

Authors:  J R Playfer; J D Baty; J Lamb; C Powell; D A Price-Evans
Journal:  Br J Clin Pharmacol       Date:  1978-12       Impact factor: 4.335

10.  Antipyrine disposition and liver size in the elderly.

Authors:  C G Swift; M Homeida; M Halliwell; C J Roberts
Journal:  Eur J Clin Pharmacol       Date:  1978-11-16       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.